Cure Magazine’s special issue on Rare Cancers, published on August 1, 2018, includes an article entitled “Waldenstrom Macroglobulinemia: The Discovery and What Lies Ahead”.
The article goes on to describe WM, its rarity, and recent advances in treatment options for… Continue reading
Recently, Dr. John Chapin, a Professor of Communications at the Pennsylvania State University’s Beaver Campus approached the IWMF about a project whereby his students would develop and produce short videos for the IWMF.
We are compiling a reading list of books that our members have recommended. Please feel free to send us titles that you have found inspiring and resourceful.
HAVE YOU READ……
“Things I wish I’d Known – Cancer Caregivers… Continue reading
October 13-14, 2018
New York Marriott Downtown Hotel and Conference Center
The Summit is planned in conjunction with the 10th International Workshop on WM (IWWM-10), October 11-13, 2018 where over 200 investigators from around the world are expected to attend.… Continue reading
Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc announced that the US Food and Drug Administration (FDA) has granted Priority Review for a supplemental New Drug Application (sNDA) for the company’s Waldenström’s macroglobulinemia combination therapy, ibrutinib (IMBRUVICA)… Continue reading
Cognitive Behavioural Therapy (CBT) as an aid for tackling anxiety. – Michael Collins
Cognitive Behavioural Therapy gives you quick, practical and goal-driven skills to help you tackle the acute anxiety that can come with a cancer diagnosis. It won’t… Continue reading
The following link is to the Cancer Therapy Advisor website featuring the following video
Meletios Dimopoulos, MD, discusses his findings at the ASCO 2018 meeting in Chicago.